Clinical Trial Update: Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed disodium and gemcitabine in advanced urothelial cancers (bladder cancer and transitional cell cancers of renal pelvis/ureter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Cancer of the Renal Pelvis and Ureter

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: COMPLETED